期刊文献+

治疗方案对2型糖尿病患者抑郁情绪影响的调查研究 被引量:11

The impact of therapeutic regimen on the depression in type 2 diabetes mellitus: A cross-sectional study
原文传递
导出
摘要 探讨胰岛素与口服降糖药物治疗对2型糖尿病患者抑郁情绪的影响。随机抽取江苏省中医院内分泌科门诊及住院的2型糖尿病患者283例,使用自行设计的问卷和Zung抑郁自评量表(SDS)开展横断面调查。利用t检验或χ2 比较不同治疗方案组患者的基本情况。应用logistic回归分析治疗方案与抑郁情绪的关系。结果显示43.1%的2型糖尿病患者存在不同程度的抑郁症状。与口服药物组相比,胰岛素组存在抑郁的比例更高(胰岛素组53.5%,口服药物组30.5%[P〈0.01),SDS得分更高[胰岛素组(51.7±12.4)分,口服药物组(44.8±10.6)分[P〈0.01]。通过校正年龄、性别、体重指数、糖尿病病程、并发症及HbA1C等多因素后,胰岛素组抑郁发生率仍高于口服药物组(OR=4.218,95% CI 1.764~13.285, P=0.004)。 胰岛素治疗是2型糖尿病患者抑郁发生的独立危险因素,有必要对此类患者加强心理支持。 To explore the depression in type 2 diabetic patients treated with insulin and compared to those treated with oral anti-diabetic drugs. 283 type 2 diabetics were seclected randomly from outpatient and inpatient departments of endocrionology in Jiangsu Province Hospital of Traditional Chinese Medicine, with the self-designed questionnaire and Zung self-rating depression scale to conduct the survey. Comparisons between the two groups were carried out with t-test or x2test for quantitative and qualitative data, respectively. Logistic regression were used for the analysis of the relationship between the therapeutic regimen and depression. Overall, 43.1% of the type 2 diabetic subjects showed depressive symptoms in different degrees. Compared to the oral drug group, the insulin group showed a significantly higher prevalence of depressive symptoms ( insulin group, 53.5% , oral drug group, 30.5% ; P〈0. 01 ) and higher self-rating depression scale scores ( insulin group, 51.7 ± 12.4, oral drug group, 44.8 ± 10.6; P〈 0. 01 ). Moreover, after an adjustment for age, sex, body mass index, diabetic duration, complications, HbAlcand so on, the insulin group showed a significantly higher frequency of depression ( OR = 4.218, 95 % CI 1. 764-13. 285, P = 0. 004) , compared to the oral drug group. The data showed that insulin treatment is an independent risk factor to the presence of depressive symptoms in type 2 diabetics, and it is necessary to pay more attention to their psychological support.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2015年第4期346-348,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 糖尿病 2型 抑郁 胰岛素 口服药 Diabetes mellitus, type 2 Depression Insulin Oral drugs
  • 相关文献

参考文献12

  • 1Roy T, Lloyd CE. Epidemiology of depression and diabetes : Asystematic review[ J]. J Affect Disord, 2012,142(Suppl) :S8-S21.
  • 2王春芳,蔡则环,徐清.抑郁自评量表-SDS对1340例正常人评定分析[J].中国神经精神疾病杂志,1986,12(5):267-268.
  • 3Van son J, Nyklicek I,Pop VJ, et al. The effects of a mindfulness-based intervention on emotional distress, quality of life, and HbAlC inoutpatients with diabetes ( DiaMind ) : a randomized controlled trial[J]. Diabetes Care, 2013,36(4) : 823-830.
  • 4李广智.抑郁症[M].北京:中国医药科技出版社.2013.
  • 5Noh JH, Park JK, Lee HJ, et al. Depressive symptoms of type 2diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs : a Korean study[ J] . Diabetes Res Clin Praet,2005,69(3):243-248.
  • 6Makine C, Kar§idag C, Kadioglu P, et al. Symptoms of depressionand diabetes-specific emotional distress are associated with a negativeappraisal of insulin therapy in insulin-naive patients with type 2 diabetesmellitus[ J]. Diabet Med, 2009,26(1) :28-33.
  • 7陆骆,周莹霞,陈钦达,朱鋐达,王琴琴,苏莉珍,赵红燕,陈宇红,徐伟人,沈翔慧,赵列宾,宁光.2型糖尿病患者抑郁与治疗方案和控制效果的关系[J].中华内分泌代谢杂志,2005,21(1):63-64. 被引量:32
  • 8Petrak F,Herpertz S,Stridde E,et al. Psychological insulin resistancein type 2 diabetes patients regarding oral antidiabetes treatment,subcutaneous insulin injections, or inhaled insulin [ J ]. DiabetesTechnol Ther, 2013,15(8) ;703-711.
  • 9Holmes-Truscott E,Pouwer F, Speight J. Further investigation of thepsychometric properties of the insulin treztment appraisal scale amonginsulin-using and non-insulin-using adults with type 2 diabetes : resultsfrom diabetes MILES-Australia[ J]. Health Qual Life Qutcomes, 2014,12(2) :87.
  • 10Meryl Brod,Jens Kongso,Donald Bushnell,于忱非,杨莉,许樟荣.中国糖尿病患者胰岛素用药行为和记忆问题网络调查[J].中国糖尿病杂志,2014,22(5):423-428. 被引量:2

二级参考文献19

  • 1Goodnick PJ, Henry JH ,Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry, 1995,56:128-136.
  • 2Lustman PJ, Griffith IS, Gavard JA, et al. Depression in adults with diabetes. Diabetes care,1992,15:1631-1639.
  • 3Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients′fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes care, 1997,20:292-298.
  • 4Suh T, Gallo JJ. Symptom profiles of depression among general medical service users compared with specialty mental health service users. Psylchol Med, 1997,27:1051-1063.
  • 5The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). Diabetes Care, 1988,11:725-733.
  • 6Zambanini A, Newson RB, Maisey M, et al. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract, 1999,46:239-246.
  • 7Anderson RJ, Freedland KE, Clouse RE, et al.The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 2001,24:1069-1078.
  • 8Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes care, 2004,27 : 1218-1224.
  • 9Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hyper- tension and dyslipidaemia:a review. Int J Clin Rract, 2008,62: 76-87.
  • 10Brod M, Rana A, Barnett AH. Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mis- timed and reduced doses. Curr Med Res Opin, 2012, 28: 1933-1946.

共引文献32

同被引文献85

引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部